Epiberberine (Protoberberine Alkaloid · Gut Microbiome · Anti-inflammatory)
| Compound | Epiberberine |
| Chemical class | Alkaloid — Isoquinoline (Protoberberine; Berberine C-8 Epimer) |
| CAS | 6873-13-8 |
| Primary source | Coptis chinensis, Berberis spp., Phellodendron spp. |
| Key applications | Anti-inflammatory, antimicrobial, neuroprotective, berberine analogue |
| Claim strength | Moderate |
| Typical form | Coptis/Berberis alkaloid extract minor co-constituent |
| Buy from Herbuno | Contact Herbuno for sourcing enquiries → |
Commercial source: Epiberberine is commercially available as a minor co-constituent of Coptis chinensis and Berberis alkaloid extracts, constituting approximately 1–4% of total alkaloid content. Isolated epiberberine is available as a research-grade material from specialist chemical suppliers. See sourcing options below. Traditional use: As a trace alkaloid in Huang Lian and barberry preparations, epiberberine participates in these plants’ traditional anti-infective, anti-inflammatory, and metabolic applications. It has not been individually targeted in traditional medicine. Research trajectory: Epiberberine has attracted research as a structural isomer of berberine (C-8 epimer with different three-dimensional configuration) that shows distinct receptor binding properties. Research has been particularly active for gut microbiome effects — epiberberine has demonstrated unique prebiotic and gut microbiome-modulating properties that differ from berberine. Anti-inflammatory and neuroprotective mechanisms parallel berberine but with structural differences enabling different binding at specific enzyme sites. See sourcing options below.
Evidence for Epiberberine Applications
Gut microbiome modulation (distinct from berberine): Epiberberine promotes growth of beneficial gut bacteria (Akkermansia muciniphila, Bifidobacterium) while suppressing pathogenic species — a prebiotic-like mechanism. Comparative studies suggest epiberberine has stronger gut microbiome modulating effects than berberine in some animal microbiome models, attributable to different gut luminal stability and transit kinetics. Claim strength: Moderate (preclinical; human data absent).
Anti-inflammatory: Epiberberine inhibits NF-κB and NLRP3 inflammasome with potency comparable to berberine in macrophage models. Its C-8 epimerism alters binding geometry at specific inflammatory kinase active sites. Anti-inflammatory efficacy in colitis animal models is documented. Claim strength: Moderate.
Neuroprotective: Epiberberine activates AMPK in neural tissue and reduces neuroinflammation (microglial activation) in cell models. BDNF upregulation has been noted. The neuroprotective profile overlaps with berberine but with potentially different CNS penetration due to structural differences. Claim strength: Moderate.
Browse Standardised Extract Powders →
Dosage & Formulator Specification
Epiberberine is not formulated as a standalone supplement. At 1–4% of total alkaloids in Berberis or Coptis extract, co-delivery alongside berberine at standard doses provides 5–20 mg epiberberine per 500 mg berberine dose. Isolated epiberberine is available from specialist chemical suppliers for research purposes. For full alkaloid complex delivery including epiberberine, specify whole-plant Berberis aristata or Coptis chinensis root extract over isolated berberine HCl.
Frequently Asked Questions — Epiberberine
What makes epiberberine different from berberine at the molecular level?
Berberine and epiberberine have the same molecular formula and most of the same structural features. They are C-8 epimers — the hydrogen at C-8 is in a different spatial orientation (alpha vs beta configuration). This seemingly minor stereochemical difference significantly alters the three-dimensional shape of the alkaloid, affecting receptor binding affinity and selectivity, metabolic stability, and gut absorption kinetics. Stereospecific enzyme and receptor binding means epiberberine can access binding sites that berberine cannot, and vice versa.
Is epiberberine’s gut microbiome effect additive with berberine?
The prebiotic-type gut microbiome modulation by epiberberine may be complementary to berberine’s microbiome effects. Berberine primarily exerts antimicrobial activity that secondarily shifts the microbiome; epiberberine appears to have more direct prebiotic properties. In the context of the full Berberis/Coptis alkaloid complex, the combined gut microbiome effects of berberine + epiberberine may provide broader and more nuanced modulation than berberine alone.
Is epiberberine produced synthetically or exclusively from plant sources?
Epiberberine occurs naturally in multiple protoberberine-containing plants and is isolated by HPLC fractionation from these botanical sources. It can also be produced semi-synthetically from berberine by C-8 epimerisation. Commercial research-grade epiberberine is typically plant-derived for botanical authenticity documentation; synthetic routes are used for high-purity research standards.
Should I specify epiberberine content when sourcing Berberis extract?
For most commercial formulations targeting berberine’s metabolic effects, berberine content specification alone is sufficient. For premium formulations specifically leveraging the full protoberberine alkaloid complexity including epiberberine’s gut microbiome contributions, requesting an individual alkaloid profile CoA reporting epiberberine alongside berberine, palmatine, jatrorrhizine, and columbamine provides comprehensive quality documentation.
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery